A comparative study of the effect of proton pump inhibitor and ranitidine on serum magnesium level and blood pressure in chronic hemodialysis patients with hypotention

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150808023559N19

Enrollment

Registered

2019-11-05

Start date

2019-10-23

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal failure. End stage renal disease

Interventions

Intervention 1: Intervention group: To first this group Tab Pantaprazol with a dose of 40 mg and Placebo of Ranitidine with a dose of 150 mg administered. Intervention 2: Control group: To control gr

Eligibility

Sex/Gender

All

Age

No minimum to 80 Years

Inclusion criteria

Inclusion criteria: ESRD patients with hypotension during dialysis

Exclusion criteria

Exclusion criteria: Serum Magnesium below 2 Antihypertensive therapy cancer Severe Congestive Heart Failure

Design outcomes

Primary

Measure	Time frame
Hypotension. Timepoint: Before starting the Hemodialysis and every 60 minutes during Hemodialysis. Method of measurement: Mercury barometer.	—

Secondary

Measure	Time frame
Hypomagnesiumia. Timepoint: Before and after intervention. Method of measurement: Lab.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Saeedi

Ardabil University of Medical Sciences

elham.saeedi2012@gmail.com+98 45 3325 1401

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 15, 2026